ArticleNeurology and therapy2023

Galcanezumab Efficacy Through the Dosing Interval in Japanese Patients with Episodic Migraine: Post Hoc Analysis of a Phase 2 Randomized Trial.

Mamoru Shibata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.